Saturday, 31 October 2026European Markets

EXMAR Stock Went Up By Over 32% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of EXMAR (BEL 20: EXM.BR) rose by a staggering 32.57% in 21 sessions from €8.78 to €11.64 at 08:15 EST on Tuesday, following the last session's downward trend. BEL 20 is jumping 0.99% to €3,807.06, after two successive sessions in a row of gains.

About EXMAR

Exmar NV provides shipping and energy supply chain solutions worldwide. It operates through three segments: Shipping, Infrastructure, and Supporting Services. The company transports liquefied gas products, such as liquid petroleum gas, butane, propane, anhydrous ammonia, and petrochemical gases. It also engages in ownership and leasing of offshore assets; development of drilling and production designs; asset construction; and provision of engineering services related to marine vessels, ships, and offshore units to the marine oil and gas industry. In addition, the company builds, owns, and operates LNG infrastructure comprising floating liquefaction of gas fields, and floating storage and regasification units, as well as provides ship-to-ship transfer services. Further, it provides ship management services, consultancy and engineering, and travel agency services; and manufactures ropes for marine and offshore applications. Additionally, the company designs, builds, installs, and operates floating production, storage, and offloading units; and operates, installs, and maintains contractor, mining companies, drilling contractors, and accommodation barges. Exmar NV was founded in 1829 and is headquartered in Antwerp, Belgium.

Earnings Per Share

As for profitability, EXMAR has a trailing twelve months EPS of €-0.19.

Volume

Today's last reported volume for EXMAR is 251460 which is 106.67% above its average volume of 121671.

Volatility

EXMAR's last week, last month's, and last quarter's current intraday variation average was 0.17%, 2.60%, and 2.18%.

EXMAR's highest amplitude of average volatility was 0.17% (last week), 3.78% (last month), and 2.18% (last quarter).

More news about EXMAR (EXM.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com